by H Hashemian 2024Monotherapy by clindamycin, clindamycin plus MSSA coverage, and clindamycin plus MRSA coverage are the most common anti-staphylococcal
MRSA (CA-. MRSA), and streptococci. Coverage for gram negative organisms is clindamycin, change clindamycin to alternate active agent such as bactrim or.
While there are other single options for coverage, they either have suboptimal MRSA coverage (i.e. clindamycin and doxycycline) or are more
While there are other single options for coverage, they either have suboptimal MRSA coverage (i.e. clindamycin and doxycycline) or are more expensive (i.e. linezolid). Without reliable ways to determine which patients need MRSA coverage, it is unclear which patients with uncomplicated cellulitis need to be discharged with MRSA coverage and
Clindamycin or vancomycin. PLUS gentamicin. Consider vancomycin for MRSA coverage in patients colonized with MRSA or with history of MRSA infection. @Add
MRSA (CA-. MRSA), and streptococci. Coverage for gram negative organisms is clindamycin, change clindamycin to alternate active agent such as bactrim or.
MRSA (CA-. MRSA), and streptococci. Coverage for gram negative organisms is clindamycin, change clindamycin to alternate active agent such as bactrim or.
MRSA (CA-. MRSA), and streptococci. Coverage for gram negative organisms is clindamycin, change clindamycin to alternate active agent such as bactrim or.
Clindamycin is a unique antibiotic with Gram-positive and MRSA coverage as well as broad anaerobic coverage. It acts by inhibiting the 50S (
Comments